|
Volumn 33, Issue 6, 2010, Pages
|
Improved glycemic control with the multi-receptor tyrosine kinase inhibitor pazopanib
|
Author keywords
[No Author keywords available]
|
Indexed keywords
EPIRUBICIN;
GLIBENCLAMIDE;
METFORMIN;
PAZOPANIB;
ANTIDIABETIC AGENT;
ANTINEOPLASTIC ANTIBIOTIC;
PYRIMIDINE DERIVATIVE;
SULFONAMIDE;
ADD ON THERAPY;
AGED;
BODY MASS;
CASE REPORT;
CLINICAL TRIAL;
DRUG WITHDRAWAL;
GASTROINTESTINAL TOXICITY;
GLUCOSE METABOLISM;
GLYCEMIC CONTROL;
HUMAN;
INSULIN RESISTANCE;
LETTER;
MALE;
NON INSULIN DEPENDENT DIABETES MELLITUS;
PHASE 1 CLINICAL TRIAL;
PROSTATE CANCER;
PROSTATECTOMY;
BLOOD;
GLUCOSE BLOOD LEVEL;
PROSTATE TUMOR;
AGED;
ANTIBIOTICS, ANTINEOPLASTIC;
BLOOD GLUCOSE;
DIABETES MELLITUS, TYPE 2;
EPIRUBICIN;
HUMANS;
HYPOGLYCEMIC AGENTS;
MALE;
PROSTATIC NEOPLASMS;
PYRIMIDINES;
SULFONAMIDES;
|
EID: 77956089366
PISSN: 01495992
EISSN: 19355548
Source Type: Journal
DOI: 10.2337/dc10-0436 Document Type: Letter |
Times cited : (12)
|
References (5)
|